Skip to main content

We earn commissions from brands listed on this site, which influences how listings are presented. Advertising Disclosure

Manytreatments
Manytreatments
BrowseCategoriesCompareMedicationsBy State
TreatmentsWeight LossED TreatmentHair LossTRT
AboutFAQContact
CategoriesCompareMedicationsBy StateWeight LossED TreatmentHair LossTRTHow We Rate

manytreatments

Compare telehealth providers for weight loss, erectile dysfunction, hair loss, TRT, women's health, mental health, and premature ejaculation treatment. Find pricing, reviews, and licensed US doctors in all 50 states.

Trustpilot

Treatments

  • Weight Loss
  • ED Treatment
  • TRT
  • Hair Loss
  • Women's Health
  • PE Treatment
  • Mental Health
  • View All Treatments →

Top Brands

  • Hims
  • Medvi
  • Ro
  • Shed
  • Eden
  • Sesame Care
  • Maximus
  • Peter MD
  • View All Brands →

Resources

  • Compare Brands
  • Browse by State
  • Medications
  • Tools
  • FAQ
  • About Us
  • Contact Us
  • How We Rate
  • Sitemap

Legal

  • Privacy Policy
  • Terms of Service
  • Affiliate Disclosure
  • Medical Disclaimer
  • Editorial Policy
  • Cookie Policy
  • California Privacy Notice (CCPA)
  • Accessibility Statement

Follow Us

  • Medium
  • YouTube
  • LinkedIn
  • Twitter/X
  • Instagram
  • Threads
© 2026 ManyTreatments.com. All rights reserved.Advertising DisclosureWe may earn commissions from affiliate links.

Content is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved for safety, effectiveness, or quality. Medical Disclaimer

  1. Home
  2. Weight Loss
  3. Liraglutide
Telehealth treatment comparison background
Eric GoldWritten by Eric GoldEditor-in-Chief
Updated onApril 05, 2026

Best Saxenda (Liraglutide) Online

Liraglutide is a GLP-1 receptor agonist available as Saxenda for weight loss and Victoza for type 2 diabetes. As one of the first GLP-1 medications for weight management, liraglutide has an established safety record with average weight loss of 5 to 10 percent of body weight. Unlike newer weekly GLP-1s, liraglutide requires daily injections.

From $500/month
5-10% Weight Loss
Daily Injections
Insurance Coverage
Compare Liraglutide providers online

Medical Disclaimer: Content is for informational purposes only—not medical advice. Consult a licensed healthcare provider before any treatment. Learn more

1
Henry Meds logo

Compounded

  • Free evaluation - pay only if prescribed
  • Choose: daily oral drops OR weekly injections
  • Medication, supplies & shipping all included
  • No insurance needed, transparent pricing
LegitScript verifiedView
8.6
Very GoodScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★☆
12,600 User Votes
Visit SiteRead full review

About This Comparison

Our Editorial Standards

This weight loss provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, service areas, and verified customer reviews.

Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers

Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.

Independent ResearchUnbiased provider comparisons
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated April 5, 2026
Licensed Providers OnlyAll listed services are US-licensed

Best Saxenda (Liraglutide) Online

Eric GoldWritten by Eric GoldEditor-in-Chief
10 min readUpdated April 5, 2026

Table of Contents

Liraglutide is a GLP-1 receptor agonist available as Saxenda for weight loss and Victoza for type 2 diabetes. As one of the first GLP-1 medications for weight management, liraglutide has an established safety record with average weight loss of 5 to 10 percent of body weight. Unlike newer weekly GLP-1s, liraglutide requires daily injections.

What Is Liraglutide and How Does It Work?

Liraglutide 3.0 mg (Saxenda) is a GLP-1 receptor agonist FDA-approved for chronic weight management. It mimics glucagon-like peptide-1 to reduce appetite, slow gastric emptying, and regulate blood sugar.
Unlike newer weekly options like Wegovy or Zepbound, Saxenda requires a daily subcutaneous injection. At the lower dose of 1.8 mg, the same medication is marketed as Victoza for type 2 diabetes management.
The medication activates GLP-1 receptors controlling appetite and satiety signals. Liraglutide 3.0 mg has been critically reviewed across the complete SCALE trial program showing consistent weight loss and metabolic improvements.
  • GLP-1 receptor agonist approved for chronic weight management
  • Daily subcutaneous injection at 3.0 mg maintenance dose
  • Available as Saxenda for weight loss and Victoza for diabetes
  • Same medication class as semaglutide with daily dosing

SCALE Trial Results: What the Research Shows

The SCALE trial enrolled 3,731 adults and demonstrated that liraglutide 3.0 mg produced an average weight loss of 8.4 kg over 56 weeks compared to 2.8 kg with placebo. 63.2% achieved at least 5% weight loss versus 27.1% on placebo, and 33.1% lost 10% or more compared to 10.6%.
The SCALE Maintenance trial showed liraglutide helped maintain prior weight loss and lose an additional 6.2% versus 0.2% with placebo after initial diet-induced weight loss. For patients with type 2 diabetes, the SCALE Diabetes trial demonstrated 6.0% weight loss with the 3.0 mg dose.
Post hoc cardiovascular analysis from SCALE trials found liraglutide 3.0 mg was not associated with excess cardiovascular risk, with a hazard ratio of 0.42 for cardiovascular events compared to placebo.
  • 8.4 kg average weight loss over 56 weeks in 3,731 patients
  • 63.2% achieved 5% or more weight loss versus 27.1% placebo
  • 33.1% achieved 10% or more weight loss
  • Improved metabolic markers including blood pressure and glucose

Saxenda vs Wegovy: Which Produces Better Results?

In the head-to-head STEP 8 trial, semaglutide 2.4 mg produced 15.8% weight loss compared to 6.4% for liraglutide 3.0 mg over 68 weeks. This significant difference has made semaglutide the preferred GLP-1 option for most patients.
Beyond efficacy, the dosing convenience differs substantially. Semaglutide requires only a weekly injection while liraglutide requires daily injections, which can affect adherence over long treatment periods.
Despite lower average weight loss than semaglutide, liraglutide has a longer safety track record and may be covered differently by insurance. Efficacy and safety are consistent across races and demographic subgroups.
  • Semaglutide (Wegovy) produces roughly double the weight loss
  • Head-to-head STEP 8 trial: 15.8% vs 6.4% weight loss
  • Saxenda requires daily injection, Wegovy is weekly
  • Saxenda may suit patients who prefer starting with a milder option

Saxenda Dosing Schedule and Administration

Saxenda dosing follows a 5-week escalation: 0.6 mg for week 1, 1.2 mg for week 2, 1.8 mg for week 3, 2.4 mg for week 4, and the maintenance dose of 3.0 mg from week 5. This gradual increase helps your body adapt and reduces gastrointestinal side effects.
Unlike semaglutide which requires weekly injection, liraglutide daily dosing provides consistent drug levels. Taking the medication at the same time each day helps establish a reliable routine.
If you cannot tolerate 3.0 mg, your provider may recommend staying at 2.4 mg or extending the escalation. Consistent daily dosing at the same time helps maintain steady medication levels.
  • Gradual dose escalation from 0.6 mg to 3.0 mg over 5 weeks
  • Daily injection at any time, with or without meals
  • Pre-filled pen injected in abdomen, thigh, or upper arm
  • Dose escalation minimizes gastrointestinal side effects

Managing Saxenda Side Effects

The most common side effects are gastrointestinal: nausea and diarrhea that are typically mild to moderate and transient. Serious adverse events occurred in 6.2% of liraglutide patients compared to 5.0% on placebo.
Saxenda carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies. It is contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2).
If you cannot tolerate 3.0 mg, your provider may recommend staying at 2.4 mg. Real-world data shows SaxendaCare patient support programs improve persistence and treatment outcomes.
  • Nausea and diarrhea are the most common side effects
  • Boxed warning for thyroid C-cell tumors from animal studies
  • Serious adverse events at 6.2% versus 5.0% on placebo
  • Report severe abdominal pain as pancreatitis risk exists

Who Qualifies for Saxenda Treatment Online?

Saxenda is approved for adults with BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity. Telehealth providers assess eligibility through health questionnaires and virtual consultations with licensed providers.
Additional contraindications include pregnancy, known hypersensitivity, and certain endocrine conditions. Providers screen for these during the consultation and review your complete medical history before prescribing.
The telehealth process involves a health assessment, medication review, and provider consultation. If Saxenda is appropriate, a prescription is sent to a pharmacy for home delivery. Some providers offer it alongside other GLP-1 options to find the best fit.
  • BMI of 30 or higher typically qualifies
  • BMI of 27 or higher with weight-related conditions may qualify
  • Thyroid cancer history is a contraindication
  • Licensed provider consultation required before prescribing

Saxenda Cost and How to Access It

Saxenda costs approximately ,300 to ,500 per month without insurance. Unlike semaglutide, there is no widely available compounded liraglutide alternative at the weight management dose, making insurance coverage or savings programs more important.
Novo Nordisk offers patient savings programs that may reduce monthly costs for commercially insured patients. Medicare and Medicaid coverage varies by plan. Check with your insurance about specific coverage requirements.
Given that semaglutide produces significantly greater weight loss at a similar or lower cost, many providers now recommend semaglutide or compounded semaglutide as a first-line GLP-1 option. Saxenda remains viable for patients with specific insurance coverage or clinical reasons.
  • Saxenda costs ,300 to ,500 per month without insurance
  • Some insurance plans cover it for weight management
  • No widely available compounded liraglutide option
  • Manufacturer savings programs may reduce costs

How to Get Saxenda Through Telehealth

Getting Saxenda through telehealth starts with a complete health assessment covering your medical history, medications, weight goals, and screening for contraindications. A licensed provider reviews your information and determines if liraglutide is appropriate.
Early weight loss with liraglutide 3.0 mg at week 12 predicts 1-year outcomes. Patients losing at least 4% at week 12 are likely to achieve clinically meaningful long-term weight loss.
Real-world clinical evaluation confirms liraglutide effectiveness for weight loss and prediabetes remission in patients awaiting bariatric surgery. If Saxenda alone is insufficient, your provider may discuss transitioning to semaglutide or tirzepatide.
  • Complete online health assessment
  • Licensed provider reviews and conducts consultation
  • Prescription sent to pharmacy for home delivery
  • Ongoing monitoring included for safe treatment

Long-Term Weight Management with Saxenda

The SCALE Maintenance trial demonstrated that continuing liraglutide after initial weight loss produced an additional 6.2% loss versus just 0.2% on placebo. This supports ongoing treatment for patients who respond well to Saxenda.
Like all weight management medications, stopping Saxenda may lead to partial weight regain. Use the treatment period to build sustainable dietary and exercise habits that support your results long-term.
Given semaglutide superior efficacy, many providers now recommend it as a first-line GLP-1 option. The LEADER trial cardiovascular data with liraglutide 1.8 mg showed cardioprotective benefits in diabetic patients.
  • SCALE Maintenance trial confirmed sustained benefits
  • Stopping treatment may lead to partial weight regain
  • Building sustainable habits during treatment is essential
  • Provider may recommend transitioning to newer options over time

Choosing the Right Provider for Saxenda

Choose a telehealth provider that offers multiple weight loss medication options, not just Saxenda. This ensures you can transition to a different medication if Saxenda does not produce adequate results or if a better-suited option becomes available.
Verify that the provider conducts thorough medical evaluations, monitors heart rate during treatment, and offers regular follow-up appointments. Quality programs provide complete oversight throughout your treatment.
Compare total program costs and what is included. Some platforms offer Saxenda alongside semaglutide and tirzepatide options, allowing you and your provider to find the optimal medication for your specific situation.
  • Look for providers offering multiple GLP-1 options
  • Ensure proper medical evaluation and ongoing monitoring
  • Compare program costs and included services
  • Ask about transition options to newer medications

Frequently Asked Questions

How much weight can you lose with liraglutide?

Clinical studies show average weight loss of 5 to 10 percent of body weight over one year with liraglutide (Saxenda). For someone weighing 200 pounds, this represents 10 to 20 pounds. Some people lose more while others lose less. Results vary based on starting weight, adherence to treatment, and lifestyle factors.

How much does liraglutide cost?

Liraglutide (Saxenda) costs $500 to $800 per month without insurance or savings programs in 2026. The manufacturer offers a savings card that can reduce costs for eligible patients. Some insurance plans cover liraglutide for weight loss. Telehealth platforms help access savings programs and insurance coverage to reduce out-of-pocket costs.

Is liraglutide the same as Saxenda?

Yes, liraglutide is the active ingredient in Saxenda. Saxenda is the brand name for liraglutide when formulated and approved for weight management. The same medication is also available as Victoza for type 2 diabetes at lower doses. Saxenda and generic liraglutide for weight loss are equivalent.

Is liraglutide better than semaglutide?

Semaglutide produces more weight loss than liraglutide on average - about 10 to 15 percent compared to 5 to 10 percent with liraglutide. Semaglutide is also injected weekly while liraglutide requires daily injections. However, liraglutide costs less and has a longer safety track record. Both are effective GLP-1 medications.

How long does it take liraglutide to work for weight loss?

Most people notice reduced appetite within the first 1 to 2 weeks of starting liraglutide. Initial weight loss typically begins within the first month. As the dose increases over several weeks to the full 3.0 mg, weight loss continues. Maximum weight loss is usually achieved at 6 to 12 months of treatment.

What are side effects of liraglutide?

Common side effects include nausea, diarrhea, constipation, vomiting, headache, and stomach discomfort. These digestive effects are usually most prominent when starting or increasing doses and typically improve within 2 to 4 weeks. Eating smaller meals and avoiding greasy or very sweet foods helps manage these effects.

Do I need a prescription for liraglutide?

Yes, liraglutide requires a prescription from a licensed healthcare provider. Telehealth platforms can prescribe liraglutide (Saxenda) after medical evaluation confirming you meet BMI requirements and have no contraindications. Online consultations make getting prescribed convenient without in-person visits.

Can you take liraglutide once a week?

No, liraglutide must be taken once daily by injection. It does not last long enough in the body for weekly dosing. If you prefer weekly injections, semaglutide (Wegovy/Ozempic) or tirzepatide (Mounjaro/Zepbound) are GLP-1 medications that are injected once weekly instead.

How do you inject liraglutide?

Liraglutide comes in pre-filled multi-dose pens. Inject once daily under the skin in your abdomen, thigh, or upper arm. The pen has a dial to set your dose and a button to inject. Rotate injection sites daily to prevent irritation. The injection takes just seconds and becomes routine quickly.

Which telehealth platform is best for liraglutide?

Ro, Calibrate, Found, and Sequence offer liraglutide (Saxenda) prescriptions through weight loss programs. Compare platforms based on consultation costs, insurance acceptance, access to manufacturer savings, daily injection support, and ongoing provider availability. Look for complete programs that provide injection training and continuous medical supervision.

Sources & References

Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.

  • Liraglutide 3.0 mg (Saxenda) is a GLP-1 receptor agonist FDA-approved for chronic weight management
  • The medication activates GLP-1 receptors controlling appetite and satiety signals. Liraglutide 3.0 mg has been critically reviewed across the complete SCALE trial program showing consistent weight loss and metabolic improvements
  • The SCALE Maintenance trial showed liraglutide helped maintain prior weight loss and lose an additional 6.2% versus 0.2% with placebo after initial diet-induced weight loss
  • Post hoc cardiovascular analysis from SCALE trials found liraglutide 3.0 mg was not associated with excess cardiovascular risk, with a hazard ratio of 0.42 for cardiovascular events compared to placebo
  • In the head-to-head STEP 8 trial, semaglutide 2.4 mg produced 15.8% weight loss compared to 6.4% for liraglutide 3.0 mg over 68 weeks
  • Despite lower average weight loss than semaglutide, liraglutide has a longer safety track record and may be covered differently by insurance. Efficacy and safety are consistent across races and demographic subgroups
  • If you cannot tolerate 3.0 mg, your provider may recommend staying at 2.4 mg. Real-world data shows SaxendaCare patient support programs improve persistence and treatment outcomes
  • Early weight loss with liraglutide 3.0 mg at week 12 predicts 1-year outcomes. Patients losing at least 4% at week 12 are likely to achieve clinically meaningful long-term weight loss
  • Real-world clinical evaluation confirms liraglutide effectiveness for weight loss and prediabetes remission in patients awaiting bariatric surgery
  • Given semaglutide superior efficacy, many providers now recommend it as a first-line GLP-1 option. The LEADER trial cardiovascular data with liraglutide 1.8 mg showed cardioprotective benefits in diabetic patients

Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards

More Weight Loss Options

Explore other weight loss treatments and providers:

All Weight Loss ProvidersFind Providers by StateBrowse All Treatments →
Eric Gold
Eric GoldEditor-in-Chief

Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.

Medical Disclaimer: The information provided on this page is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. Always verify with your chosen provider. Read our full medical disclaimer.